4//SEC Filing
Henig Yair Steve 4
Accession 0001209191-10-049463
CIK 0001180262other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 7:57 PM ET
Size
10.8 KB
Accession
0001209191-10-049463
Insider Transaction Report
Form 4
Henig Yair Steve
Chief Scientific Officer
Transactions
- Disposition to Issuer
Common Stock
2010-10-01$60.84/sh−8,196$498,645→ 11,580 total - Exercise/Conversion
Stock Appreciation Rights
2010-10-01−10,000→ 16,083 totalExercise: $40.25Exp: 2017-05-29→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2010-10-01$40.25/sh+10,000$402,500→ 19,776 total - Sale
Common Stock
2010-10-05$61.00/sh−1,804$110,044→ 9,776 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2010.
- [F2]Consists of stock appreciation rights granted under the Herbalife Ltd. 2005 Stock Incentive Plan, of which 20% vested on May 29, 2008, 20% vested on May 29, 2009 and the remaining 60% vested on May 29, 2010.
Documents
Issuer
HERBALIFE LTD.
CIK 0001180262
Entity typeother
Related Parties
1- filerCIK 0001434625
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 7:57 PM ET
- Size
- 10.8 KB